[go: up one dir, main page]

TR200102916T2 - Nötrleştirilmiş basınca duyarlı akrilat yapışkanlar ihtiva eden transdermal terapötik sistem - Google Patents

Nötrleştirilmiş basınca duyarlı akrilat yapışkanlar ihtiva eden transdermal terapötik sistem

Info

Publication number
TR200102916T2
TR200102916T2 TR2001/02916T TR200102916T TR200102916T2 TR 200102916 T2 TR200102916 T2 TR 200102916T2 TR 2001/02916 T TR2001/02916 T TR 2001/02916T TR 200102916 T TR200102916 T TR 200102916T TR 200102916 T2 TR200102916 T2 TR 200102916T2
Authority
TR
Turkey
Prior art keywords
pressure sensitive
transdermal therapeutic
therapeutic system
acrylate adhesives
salts
Prior art date
Application number
TR2001/02916T
Other languages
English (en)
Inventor
Bracht Stefan
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of TR200102916T2 publication Critical patent/TR200102916T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Nötrlestirilmis basinca duyarli akrilat yapiskanlar ihtiva eden transdermal terapötik sistem, ki bu sistem bünyesinde; - en az bir tane bazik yada nötr davranan farmasötik etken madde ihtiva eden, - zincirilerinde akrilik asit ya da metakrilik asit birimlerine sahip bir poliakrilat basinca duyarli yapiskan ihtiva eden, karboksil gruplarinin miktarinin, ortalama polimer kütlesine göre, %0.5 ile %10.0 (w./w) arasinda oldugu ve karboksil gruplarinin fizyolojik olarak %5 ile %100 (tercihen %10 ile %50) arasindaki miktarinin alkali tuzlari yada alalin toprak tuzlari seklinde bulundugu bir ana madde veya bir havuz sisteni olarak ifade edilmektedir. Neme duyarliligi azaltmak amaciyla, sistem içerisinde su baglayici katki maddeleri de yer alabilir.
TR2001/02916T 1999-04-22 2000-04-07 Nötrleştirilmiş basınca duyarlı akrilat yapışkanlar ihtiva eden transdermal terapötik sistem TR200102916T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19918106A DE19918106A1 (de) 1999-04-22 1999-04-22 Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern

Publications (1)

Publication Number Publication Date
TR200102916T2 true TR200102916T2 (tr) 2002-01-21

Family

ID=7905368

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02916T TR200102916T2 (tr) 1999-04-22 2000-04-07 Nötrleştirilmiş basınca duyarlı akrilat yapışkanlar ihtiva eden transdermal terapötik sistem

Country Status (26)

Country Link
US (1) US6689379B1 (tr)
EP (1) EP1171104B1 (tr)
JP (4) JP2002542277A (tr)
KR (1) KR100693824B1 (tr)
CN (1) CN1204879C (tr)
AR (1) AR023549A1 (tr)
AT (1) ATE364379T1 (tr)
AU (1) AU779960B2 (tr)
BR (1) BR0011131A (tr)
CA (1) CA2370019C (tr)
CZ (1) CZ302169B6 (tr)
DE (2) DE19918106A1 (tr)
DK (1) DK1171104T3 (tr)
ES (1) ES2288851T3 (tr)
HK (1) HK1045264B (tr)
HU (1) HU227693B1 (tr)
IL (2) IL145948A0 (tr)
MX (1) MXPA01010504A (tr)
NZ (1) NZ514946A (tr)
PL (1) PL200815B1 (tr)
PT (1) PT1171104E (tr)
RU (1) RU2242971C2 (tr)
TR (1) TR200102916T2 (tr)
TW (1) TWI275400B (tr)
WO (1) WO2000064418A2 (tr)
ZA (1) ZA200108564B (tr)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2331264C (en) 1999-01-14 2008-09-23 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
US20030170195A1 (en) 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
KR100533493B1 (ko) * 2000-11-17 2005-12-06 데이진 가부시키가이샤 에스트라디올 함유 부착제
DE10103860B4 (de) * 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE10110391A1 (de) 2001-03-03 2002-09-26 Lohmann Therapie Syst Lts Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
JP4295467B2 (ja) 2002-04-12 2009-07-15 日東電工株式会社 貼付剤およびその製造方法
CA2529528A1 (en) 2003-06-20 2004-12-29 Ronald Aung-Din Topical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
US20070077285A1 (en) * 2003-11-21 2007-04-05 Hiroko Udagawa Adhesive skin patch
ITMI20041628A1 (it) * 2004-08-06 2004-11-06 Bouty S P A Sistema terapeutico a rilascio controllato per uso topico transdermico
US20060078602A1 (en) 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Device for transdermal administration of drugs including acrylic polymers
DE102005010255A1 (de) 2005-03-07 2006-09-14 Lts Lohmann Therapie-Systeme Ag Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
ITMI20050477A1 (it) * 2005-03-23 2006-09-24 Bouty S P A Cerotto transdermico
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
JP5015562B2 (ja) * 2005-12-13 2012-08-29 日東電工株式会社 貼付製剤
JP5285279B2 (ja) * 2005-12-28 2013-09-11 久光製薬株式会社 経皮吸収型製剤
JP5190358B2 (ja) * 2006-02-28 2013-04-24 久光製薬株式会社 経皮吸収型製剤
AU2006343077B2 (en) * 2006-05-08 2012-11-08 Teikoku Seiyaku Co., Ltd. Tansdermally absorbable preparation comprising anti-dementia agent
KR100725024B1 (ko) * 2006-06-05 2007-06-07 주식회사 덕성 고흡수성 하이드로콜로이드의 제조방법
JP5192296B2 (ja) * 2007-07-05 2013-05-08 日東電工株式会社 貼付剤および貼付製剤
JP5097034B2 (ja) * 2007-07-20 2012-12-12 日東電工株式会社 貼付剤および貼付製剤
KR100956023B1 (ko) * 2007-09-28 2010-05-06 대화제약 주식회사 산성 관능기를 갖는 아크릴레이트계 고분자의 함량으로약물 방출속도를 제어하는 툴로부테롤 경피 투여용 패취제
JP5209433B2 (ja) * 2007-10-19 2013-06-12 日東電工株式会社 貼付製剤
CA2729346A1 (en) 2008-06-30 2010-01-14 Afgin Pharma, Llc Topical regional neuro-affective therapy
ITMI20081552A1 (it) * 2008-08-29 2010-02-28 Biofarmitalia Spa Composizione migliorata per la trasmissione topica di principi attivi nel corpo umano od animale
WO2011011318A1 (en) * 2009-07-21 2011-01-27 Mylan, Inc. Process for the continuous manufacture of a polyisobutylene based transdermal patch
US8221994B2 (en) * 2009-09-30 2012-07-17 Cilag Gmbh International Adhesive composition for use in an immunosensor
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
EP2515886B1 (de) * 2009-12-22 2018-04-11 Luye Pharma AG Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten
CA2793571C (en) 2010-04-30 2015-10-13 Teikoku Pharma Usa, Inc. Propynylaminoindan transdermal compositions
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
CN102559110A (zh) * 2010-12-09 2012-07-11 湖北航天化学技术研究所 乳液型有机硅改性丙烯酸酯压敏胶及其制备方法和应用
PL2468274T3 (pl) * 2010-12-14 2015-11-30 Luye Pharma Ag Przezskórny układ terapeutyczny do podawania substancji czynnej
WO2012129429A2 (en) 2011-03-24 2012-09-27 Teikoku Pharma Usa, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer
EP2752188B1 (en) 2011-08-31 2020-05-06 Toyo Ink Sc Holdings Co., Ltd. Adhesive patch
WO2013047410A1 (ja) * 2011-09-28 2013-04-04 ニチバン株式会社 持続型アルツハイマー病治療用貼付剤及びその製造方法
US9913812B2 (en) 2011-11-09 2018-03-13 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
US10470936B2 (en) 2012-02-29 2019-11-12 Hollister Incorporated Buffered adhesive compositions for skin-adhering medical products
JP6092243B2 (ja) * 2012-02-29 2017-03-08 ホリスター・インコーポレーテッドＨｏｌｌｉｓｔｅｒ Ｉｎｃｏｒｐｏｒａｔｅｄ 皮膚粘着医療製品用の緩衝粘着剤組成物
US10758494B2 (en) 2012-06-12 2020-09-01 KM Transderm Ltd. Rivastigmine-containing adhesive patch
JP6269488B2 (ja) * 2012-09-03 2018-01-31 ニプロ株式会社 貼付剤
US9895320B2 (en) 2012-09-28 2018-02-20 KM Transderm Ltd. Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer
KR101856515B1 (ko) 2012-11-02 2018-05-10 테이코쿠 팔마 유에스에이, 인코포레이티드 프로피닐아미노인단 경피 조성물
TWI635876B (zh) * 2013-03-15 2018-09-21 香港商安能泰製藥有限公司 含有利凡斯的明（ｒｉｖａｓｔｉｇｍｉｎｅ）的經皮藥物傳輸系統
BR112016006976A2 (pt) * 2013-10-01 2017-08-01 Novartis Ag combinação
RU2648449C2 (ru) 2013-10-07 2018-03-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина
RU2646512C2 (ru) * 2013-10-07 2018-03-05 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Устройства для трансдермальной доставки дексмедетомидина и способы их применения
KR101831290B1 (ko) * 2013-10-07 2018-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 조성물을 사용하여 주의력 결핍 과잉행동 장애, 불안 및 불면증을 치료하기 위한 방법 및 조성물
CN106413695B (zh) * 2014-04-08 2019-12-10 帝国制药美国公司 利伐斯的明透皮组合物及其使用方法
RU2723761C1 (ru) 2016-10-31 2020-06-17 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы устранения боли с использованием устройств для трансдермальной доставки дексмедетомидина
CN106634704A (zh) * 2016-12-08 2017-05-10 苏州艾博迈尔新材料有限公司 一种抗过敏医用压敏胶及其制备工艺
RU2764443C2 (ru) 2016-12-20 2022-01-17 Лтс Ломанн Терапи-Систем Аг Трансдермальная терапевтическая система, содержащая азенапин и полисилоксан или полиизобутилен
RU2762896C2 (ru) 2016-12-20 2021-12-23 Лтс Ломанн Терапи-Систем Аг Трансдермальная терапевтическая система, содержащая азенапин
BR112019027037B1 (pt) 2017-06-26 2022-04-05 Lts Lohmann Therapie-Systeme Ag Sistema terapêutico transdérmico contendo asenapina e polímero híbrido acrílico de silicone, e processo para fabricar uma camada contendo asenapina para uso no referido sistema
CN107320463A (zh) * 2017-07-10 2017-11-07 徐静 一种含有单硝酸异山梨酯的缓释透皮贴剂及其应用
WO2019068288A1 (de) 2017-10-04 2019-04-11 Berlimed International Research Gmbh Wirkstoff und wirkstoffmatrix enthaltendes produkt zur transdermalen wirkstoffabgabe sowie dessen herstellung und verwendung sowie die wirkstoffmatrix, ihre herstellung und verwendung
TWI857942B (zh) 2017-10-30 2024-10-11 日商帝國製藥股份有限公司 經皮投與製劑
US11648213B2 (en) 2018-06-20 2023-05-16 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
CN112533593A (zh) 2018-06-20 2021-03-19 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统
US11752114B2 (en) * 2019-04-17 2023-09-12 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system
JP2022550569A (ja) 2019-10-03 2022-12-02 スタートン セラピューティクス，インコーポレイティド ドロナビノールの経皮送達
US12409131B2 (en) 2019-10-03 2025-09-09 Pike Therapeutics Usa, Inc. Transdermal delivery of dronabinol
CA3155176A1 (en) 2019-10-11 2021-04-15 Pike Therapeutics, Inc., 1219014 B.C. Ltd. Transdermal compositions comprising cannabidiol (cbd) for use in the treatment of seizure disorders
US12016829B2 (en) * 2019-10-11 2024-06-25 Pike Therapeutics Inc. Pharmaceutical composition and method for treating seizure disorders

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE279611C (tr)
JPS5259636A (en) * 1975-11-11 1977-05-17 Soken Kagaku Kk Composition of pressure sensitive adhesive
DD279611A1 (de) * 1985-03-07 1990-06-13 Univ Ernst Moritz Arndt Verfahren zur herstellung einer haftarzneiform
DE3682165D1 (de) * 1985-11-08 1991-11-28 Nitto Denko Corp Verwendung von heftpflastern fuer die haut und perkutanen praeparaten.
JP2632838B2 (ja) * 1986-10-23 1997-07-23 久光製薬 株式会社 外用貼付剤
JPS63137746A (ja) * 1986-12-01 1988-06-09 Lion Corp マイクロカプセル及びその製造方法
DE69009540T2 (de) * 1989-03-15 1994-09-29 Nitto Denko Corp Arzneimittel enthaltendes Heftpflaster.
JP2693212B2 (ja) * 1989-03-28 1997-12-24 日東電工株式会社 疾患治療用テープ製剤
DE3913734C2 (de) * 1989-04-26 1998-08-20 Roehm Gmbh Verwendung einer wäßrigen Hauthaftkleberlösung zur Herstellung einer mit Wasser leicht abwaschbaren Klebschicht
JP3046346B2 (ja) * 1990-03-12 2000-05-29 昭和電工株式会社 外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤
JP3308593B2 (ja) * 1992-06-19 2002-07-29 日東電工株式会社 機能性外用材及びその製造方法
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
JPH06346041A (ja) * 1993-06-10 1994-12-20 Showa Denko Kk 親水性粘着剤組成物
CA2117546A1 (en) * 1993-08-27 1995-02-28 Takateru Muraoka Medical adhesive sheet
JP3451125B2 (ja) * 1993-12-27 2003-09-29 ニチバン株式会社 粘着テープ及びその製造方法
JPH07206710A (ja) * 1994-01-21 1995-08-08 Nitto Denko Corp 経皮投薬用テープ製剤
MX9603667A (es) * 1994-03-07 1997-06-28 Theratech Inc Dispositivo de suministro transdermico compuesto adhesivo que contiene droga.
FR2717689B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base de copolymère styrène-isoprène-styrène.
JPH07330602A (ja) * 1994-06-13 1995-12-19 Nitto Denko Corp 経皮吸収型ピロカルピン製剤
DE4423850A1 (de) * 1994-07-07 1996-01-11 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Naloxon
DE4429791C2 (de) * 1994-08-23 1997-04-24 Lohmann Therapie Syst Lts Medizinischer Haftkleber auf Basis von Polyacrylaten und dessen Verwendung
JP3361674B2 (ja) * 1995-11-08 2003-01-07 日本カーバイド工業株式会社 医療用粘着剤組成物
JPH09143061A (ja) * 1995-11-20 1997-06-03 Showa Denko Kk 鎮痛剤用経皮吸収製剤
JP3497309B2 (ja) * 1995-12-22 2004-02-16 積水化学工業株式会社 貼付剤
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
JPH10316590A (ja) * 1997-05-14 1998-12-02 Showa Denko Kk 局所麻酔用外用剤
DE19728516C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Levonorgestrel und gegebenenfalls Estradiol
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
AU779960B2 (en) 2005-02-24
DE19918106A1 (de) 2000-10-26
HUP0200635A2 (hu) 2002-07-29
WO2000064418A3 (de) 2001-03-15
TWI275400B (en) 2007-03-11
DK1171104T3 (da) 2007-10-15
EP1171104B1 (de) 2007-06-13
BR0011131A (pt) 2003-08-12
HK1045264B (zh) 2005-09-16
ZA200108564B (en) 2002-09-11
JP2015108007A (ja) 2015-06-11
CA2370019C (en) 2010-06-08
JP6170082B2 (ja) 2017-07-26
US6689379B1 (en) 2004-02-10
JP2013082727A (ja) 2013-05-09
RU2242971C2 (ru) 2004-12-27
ATE364379T1 (de) 2007-07-15
MXPA01010504A (es) 2002-06-04
CA2370019A1 (en) 2000-11-02
ES2288851T3 (es) 2008-02-01
AU4294200A (en) 2000-11-10
CN1354654A (zh) 2002-06-19
PL200815B1 (pl) 2009-02-27
NZ514946A (en) 2004-02-27
JP5719500B2 (ja) 2015-05-20
WO2000064418A2 (de) 2000-11-02
HK1045264A1 (en) 2002-11-22
CZ302169B6 (cs) 2010-11-24
PT1171104E (pt) 2007-09-21
CN1204879C (zh) 2005-06-08
HUP0200635A3 (en) 2006-07-28
EP1171104A2 (de) 2002-01-16
IL145948A (en) 2006-10-31
AR023549A1 (es) 2002-09-04
KR20010112452A (ko) 2001-12-20
HU227693B1 (en) 2011-12-28
JP2009051840A (ja) 2009-03-12
JP2002542277A (ja) 2002-12-10
CZ20013763A3 (cs) 2002-02-13
KR100693824B1 (ko) 2007-03-12
PL352550A1 (en) 2003-08-25
IL145948A0 (en) 2002-07-25
DE50014413D1 (de) 2007-07-26

Similar Documents

Publication Publication Date Title
TR200102916T2 (tr) Nötrleştirilmiş basınca duyarlı akrilat yapışkanlar ihtiva eden transdermal terapötik sistem
TR200102793T2 (tr) Biyo-indirgenen selüloz asetat yapısı ve tütün filtresi
ATE286715T1 (de) Gastrointestinale an der mucosa haftende pharmazeutische zusammensetzung
TWI349558B (tr)
EP0072251A2 (en) Improved bandage containing a medicament
TR200102002T2 (tr) Ağız yoluyla verildikten sonra gliklazid'in uzun sürede salınmasını sağlayan matris tablet.
FR2785092B1 (fr) Pile zinc-air amelioree et ses utilisations
ATE306254T1 (de) Zubereitungen mit verbesserter kontrollierter freisetzung
TR200001215A2 (tr) Cildin pH değerini dengeleyen bir terkip ihtiva eden losyonlu kağıt mendil ürünleri
BR0016828A (pt) Polìmeros superabsorventes
NZ507631A (en) Adhesive microsphere transdermal drug delivery composition comprising at least 10 weight % of a softening agent incorporated within the microspheres
PT904062E (pt) Conjugado ionico
BR0015592A (pt) Adesivo cheio com particulado orgânico, e, tira cosmética
ES2101511T3 (es) Asociacion espesante a base de goma de guar o de celulosa no ionica y de un polimero reticulado y composicion cosmetica o dermatologica para el tratamiento de los cabellos o de la piel, que contiene dicha asociacion.
ES2196055T3 (es) Dispositivo transdermico que contiene polivinilpirrolidona como intensificador de la solubilidad.
ES2147858T3 (es) Matriz para el suministro transdermico de farmacos.
TR200101339T2 (tr) Potasyum kanal modülatörleri olarak 3-yer-alanlı-4-arilkinolin-2-on türevleri, 3,4-okzadiazolon türevleri
TR199902484T2 (tr) Biyolojik yönden aktif maddeler ihtiva eden yapisici mikrokapsüller
FR2799366B1 (fr) Composition sous forme d'emulsion huile-dans-eau contenant des fibres, et ses utilisations notamment cosmetiques
CA2145547A1 (en) Skin treatment with adhesion enhancement properties
EP0879597A4 (en) TRANSPARENT AQUEOUS SOLUTION OF SODIUM DICLOFENAC AND MEDICINAL PRODUCTS USED THEREOF
HUP9900315A2 (hu) Hőhatásra megolvadó, nyomásra tapadó ragasztókompozíciók és azok alkalmazása, valamint öntapadó szalagok, sebkötöző szerek, ragtapaszok és címkék
TR200402071T4 (tr) Montaj için sulu polimer dispersiyonu esaslı yapıştırıcı.
ATE381313T1 (de) Hautpflegevorrichtung mit hautbleichmittel
TR200003839T2 (tr) Hormon ve kristalleşmeyi engelleyen maddeler içeren transdermal terapi sistemi